The present call is supported by 22 member countries: Australia, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Latvia, Luxembourg, Netherlands, Norway, Poland, Portugal (Azores), Slovakia, Spain, Sweden, Switzerland, and Turkey.
Proposals should focus on one or several of the following research areas:
Proposals focusing on one of the following neurodegenerative diseases are eligible for this call: Alzheimer’s disease and other dementias, Parkinson’s disease and PD‐related disorders, Prion diseases, Motor neuron diseases, Huntington’s disease, Spinocerebellar ataxia (SCA), Spinal muscular atrophy (SMA)
Proposals should have novel, ambitious aims and ideas combined with well-structured work plans and clearly defined objectives deliverable within three years. Where proposals are complementary to work funded or applied for under other initiatives, this should be indicated, so that it is clear how any work supported by JPND will add value. Each consortium should have the critical mass to achieve the identified scientific goals and the proposals should specify the added value of working together. Applicants should demonstrate that they have the expertise and range of skills required to conduct the research project or that appropriate collaborations are in place. The value that will be added to ongoing national activities and the expected impact on future medical as well as health and social care for people suffering from neurodegenerative diseases should be explicitly stated.
Proposals should address socio-economic factors, gender-related research questions and comorbidities, where appropriate. Consortia should incorporate these factors when formulating their research hypotheses, aims and work plans. Cross-cultural issues and diversity, should be taken into account, particularly when developing and implementing instruments and intervention strategies. Patient and Public involvement at all the stages of the proposals is highly encouraged.
Contac Persons for the Joint Call Secretariat Sabrina Voß (+49) 228-3821 2111 or sabrina.voss(at)dlr.de
ANR contact Dr. Sheyla Mejia-Gervacio sheyla.mejia(at)anr.fr + 33 1 78 09 80 14